C-HBP

T:HBP - HELIX BIOPHARMA CORP. - https://www.helixbiopharma.com

21:25:29 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
HBP - T	0.1	1.58	·	2.02	0.3	1.64			0.9	1	22	1.60 1.64 1.60	5.40 0.84	15:59:52	Mar 16	15 min RT 2¢
TSX - T	0.1	1.58	·	2.02	0.3	1.64			0.5	0	8	1.60 1.64 1.60	5.40 0.84	15:59:52		15 min
CXC - X						1.60	-0.04	-2.4	0.1	0	1	1.60 1.60 1.60		14:53:39		15 min
CXD - D						1.62	-0.02	-1.2	0.2	0	5	1.62 1.62 1.62		10:48:41		15 min
MatchNOW - M						1.64			0.1	0	7			Sep 01/20		15 min
CS2 - S						1.64			0.04		1					15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Options · Shorts · Portfolio

Recent Trades - Last 10 of 22

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:52	T	1.64		100	1 Anonymous	7 TD Sec	K
15:30:34	M	1.64		3	7 TD Sec	80 National Bank	E
14:53:39	M	1.60	-0.04	99	2 RBC	1 Anonymous	E
14:53:39	X	1.60	-0.04	100	80 National Bank	2 RBC	K
14:53:39	T	1.60	-0.04	100	7 TD Sec	79 CIBC	K
14:42:48	D	1.64		50	80 National Bank	80 National Bank	E
14:32:50	S	1.60	-0.04	35	7 TD Sec	19 Desjardins	E
14:11:58	M	1.63	-0.01	2	2 RBC	7 TD Sec	E
13:22:51	D	1.64		29	80 National Bank	80 National Bank	E
12:25:07	M	1.60	-0.04	1	80 National Bank	80 National Bank	E

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2026-03-16 17:00	C:HBP	1.79	News Release200	Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026
2026-03-16 16:23	C:HBP		SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2026-03-16 16:23	C:HBP		SEDAR Interim MD & A813	SEDAR Interim MD & A
2026-02-24 09:00	C:HBP	2.00	News Release200	Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC London
2026-02-05 16:30	C:HBP	1.83	News Release200	Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases
2026-01-30 18:03	C:HBP	2.03	News Release200	Helix BioPharma holders OK all business items at AGM
2025-12-15 17:30	C:HBP	2.05	News Release200	Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025
2025-12-12 16:25	C:HBP	2.04	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-12-12 16:25	C:HBP	2.04	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-10-29 17:59	C:HBP		SEDAR MD & A815	SEDAR MD & A
2025-10-29 13:52	C:HBP	2.09	SEDAR Annual Information Form802	SEDAR Annual Information Form
2025-10-29 12:45	C:HBP	2.09	News Release200	Helix BioPharma Corp. Announces Fiscal 2025 Year-End Results
2025-10-29 11:53	C:HBP	2.09	SEDAR MD & A815	SEDAR MD & A
2025-10-29 11:48	C:HBP	2.09	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2025-10-06 21:39	C:HBP	5.31	News Release200	Helix BioPharma does not say why trading is up
2025-09-09 16:15	C:HBP	1.48	News Release200	Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025
2025-09-05 18:54	C:HBP	1.45	News Release200	Helix ends review, drops GEM equity facility plan
2025-08-22 18:27	C:HBP	1.35	News Release200	Helix BioPharma closes $1.66-million private placement
2025-08-13 19:29	C:HBP	1.12	News Release200	Helix publishes article in Frontiers in Oncology

Date ET

Symbol

Price

Type

Headline

2026-03-16 17:00

C:HBP

1.79

News Release

Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026

2026-03-16 16:23

C:HBP